Log in to save to my catalogue

Selective tissue targeting of synthetic nucleic acid drugs

Selective tissue targeting of synthetic nucleic acid drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6391085

Selective tissue targeting of synthetic nucleic acid drugs

About this item

Full title

Selective tissue targeting of synthetic nucleic acid drugs

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2019-03, Vol.129 (3), p.915-925

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Antisense oligonucleotides (ASOs) are chemically synthesized nucleic acid analogs designed to bind to RNA by Watson-Crick base pairing. Following binding to the targeted RNA, the ASO perturbs RNA function by promoting selective degradation of the targeted RNA, altering RNA intermediary metabolism, or disrupting function of the RNA. Most antisense d...

Alternative Titles

Full title

Selective tissue targeting of synthetic nucleic acid drugs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6391085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6391085

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI125228

How to access this item